Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Clinical Study on Safety and Efficacy of Quadrivalent Influenza Virus Split Vaccine in Larger Population

NCT06334510 is registered in ClinicalTrials.gov with Hualan Biological Bacterin Co. Ltd. as lead sponsor.

NCT NCT06334510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06334510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Clinical Study on Safety and Efficacy of Quadrivalent Influenza Virus Split Vaccine in Larger Population
Lead sponsor
Hualan Biological Bacterin Co. Ltd.
Phase
Observational
Overall status
Completed
Start date
November 17, 2021
Completion date
March 28, 2023
Enrollment
4,900 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gcp